Published in Genetics and Environmental Health Week, June 14th, 2006
This trend article about Nagoya City University is an immediate alert from NewsRx to identify developing directions of research.
Study 1: ABCG2 expression may be useful as a biomarker of lung cancer resistance to CPT-11/SN-38 treatment.
To "examine the mechanism of resistance to 7-ethyl-10-hydroxycamptothecin (SN-38) in lung cancer," scientists in Japan "continuously exposed the nonsmall-cell lung cancer (NSCLC) cell line NCI-H23 to SN-38 and selected the SN-38-resistant clone H23/SN-38."
"After 2 months of culturing in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Health Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.